Catherine M Kasse

Title: Innovations in Antibody Biopharmaceuticals by Catherine M Kasse

Introduction

Catherine M Kasse is a prominent inventor based in Menlo Park, CA (US). She has made significant contributions to the field of biopharmaceuticals, particularly in the development of antibody formulations. With a total of 2 patents, her work focuses on enhancing the stability and efficacy of antibody compositions.

Latest Patents

Catherine's latest patents revolve around antibody biopharmaceutical formulations that include polymer excipients. Specifically, her work with polyacrylamide-based copolymers acts as stabilizing excipients in these formulations. These copolymers do not interact directly with the antibody or alter its pharmacokinetic properties. They provide substantial stability benefits to high concentration compositions of various antibodies by preventing adsorption to the interfaces of the composition. This innovation helps to avoid undesirable aggregation events and maintains the binding activity of the antibody. Such compositions are crucial for effective administration methods to subjects.

Career Highlights

Catherine M Kasse is affiliated with Leland Stanford Junior University, where she continues her research and development in biopharmaceuticals. Her innovative work has positioned her as a key figure in the field, contributing to advancements that can significantly impact therapeutic applications.

Collaborations

Catherine has collaborated with notable colleagues, including Joseph L Mann and John Klich. These partnerships have further enriched her research and development efforts in the biopharmaceutical domain.

Conclusion

Catherine M Kasse's contributions to antibody biopharmaceutical formulations demonstrate her commitment to innovation in the field. Her work not only enhances the stability of antibody compositions but also paves the way for improved therapeutic applications.